Explore the concept of the MS prodrome, a period with subtle symptoms before multiple sclerosis onset. Learn about early ...

A team from UNIGE and HUG has discovered a subgroup of immune cells particularly involved in the disease, opening the way to ...

—In clinical trials of MS treatments, NEDA rates at 2 years are < 50%, but there's a need to gather longer-term data to determine the durability of NEDA. Reviewed by Aaron Miller, MD, Professor of ...

Proteomics helped uncover molecular signatures of multiple sclerosis up to seven years before symptom onset, paving the way ...

WEST LAFAYETTE, Ind. — A biomarker for multiple sclerosis that could be an early warning for the disease has shown promise in both human and animal testing. Researchers at Purdue University and the ...

Multiple sclerosis is a chronic disease where your immune system starts attacking your brain and spinal cord. The number of people living with the condition has grown to 913,925—current estimates ...

An analysis of data from phase 3 randomized controlled trials showed that among individuals with comparable disease duration, inflammatory disease activity was significantly lower in older trial ...

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), likely contributing to the persistent inflammation characteristic of the ...

Please provide your email address to receive an email when new articles are posted on . Chart review yielded 38 persons with MS and cancer treated with immune checkpoint inhibitors. Thirteen patients ...